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Abstract
Herpes simplex virus type 1 (HSV-1) and HSV-2 are highly prevalent viruses that cause a
variety of diseases, from cold sores to encephalitis. Both viruses establish latency in periph-
eral neurons but the molecular mechanisms facilitating the infection of neurons are not fully
understood. Using surface plasmon resonance and crosslinking assays, we show that
glycoprotein G (gG) from HSV-2, known to modulate immune mediators (chemokines), also
interacts with neurotrophic factors, with high affinity. In our experimental model, HSV-2 se-
creted gG (SgG2) increases nerve growth factor (NGF)-dependent axonal growth of sympa-
thetic neurons ex vivo, and modifies tropomyosin related kinase (Trk)A-mediated signaling.
SgG2 alters TrkA recruitment to lipid rafts and decreases TrkA internalization. We could
show, with microfluidic devices, that SgG2 reduced NGF-induced TrkA retrograde trans-
port. In vivo, both HSV-2 infection and SgG2 expression in mouse hindpaw epidermis en-
hance axonal growth modifying the termination zone of the NGF-dependent peptidergic
free nerve endings. This constitutes, to our knowledge, the discovery of the first viral protein
that modulates neurotrophins, an activity that may facilitate HSV-2 infection of neurons.
This dual function of the chemokine-binding protein SgG2 uncovers a novel strategy devel-
oped by HSV-2 to modulate factors from both the immune and nervous systems.
Author Summary
Herpes simplex virus type 1 and 2 (HSV-1 and HSV-2, respectively) establish latency in
peripheral sensory ganglia, where they remain for the lifetime of the infected individual.
Understanding the mechanisms that allow these viruses to colonize the nervous system
will permit devising antiviral strategies. We show that HSV-2 glycoprotein G (SgG2) binds
to and increases the function of nerve growth factor (NGF), a neurotrophin expressed in
the skin and mucosa essential for axonal growth and neuronal survival. This constitutes
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the first description, to our knowledge, of a human pathogen with the ability to augment
neurotrophic factor function. The enhancement in NGF activity results in an increase in
axonal growth of neurons expressing the receptor for NGF. These results were obtained in
vitro, ex vivo and in the infected mouse, suggesting that this effect may permit a more effi-
cient infection of NGF dependent free nerve endings by HSV-2. Absence of a similar func-
tion for HSV-1 gG may indicate a preference for the infection of particular subsets of
neurons by these viruses. These results shed light on the modulation of neurotrophic fac-
tors by relevant human pathogens and on the mechanisms of colonization of the nervous
system by HSV.
Introduction
Herpes simplex virus type 1 and 2 (HSV-1 and HSV-2, respectively) are highly prevalent, neu-
rotropic human pathogens [1]. Initial infection occurs in epithelial cells, generally within the
skin and the mucosa of the oral tract and genitalia [1]. Then, HSV reaches and infects free
nerve endings (FNE) of sensory neurons and colonizes ganglia of the Peripheral Nervous Sys-
tem (PNS). The mechanism(s) facilitating HSV neurotropism, which is crucial for latency and
pathogenesis, are not well understood. Since herpesviruses are highly adapted pathogens that
modify several aspects of both the immune and nervous systems, it is conceivable that they
may modulate factors influencing neuronal functions to gain access to the nervous system. Sev-
eral axonal guidance cues and neurotrophic factors involved in neural targeting have been
identified [2]. Among them, neurotrophins are a family of secreted proteins that play relevant
roles in neuronal survival, axonal growth and guidance in the PNS. Members of this family in-
clude nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3
(NT3) and NT4/5 [3]. Each neurotrophin binds with high affinity and activates tyrosine kinase
receptors known as Trks. NGF binds TrkA, BDNF and NT4/5 bind TrkB, and NT3 binds
TrkC. Moreover, NT3 can also bind TrkA and TrkB, although with lower affinity [3]. Both ma-
ture neurotrophins and immature precursors (proneurotrophins) also bind p75 neurotrophin
receptor (p75NTR), a member of the tumor necrosis factor (TNF) receptor superfamily.
p75NTR has multiple and diverse functions [4]. Another important family of neurotrophic fac-
tors is the glial cell line-derived neurotrophic factors (GDNF) family ligands (GFLs) formed by
GDNF and artemin among others. GFLs interact with co-receptors of the GDNF Family Re-
ceptor α (GFRα) protein family, allowing the activation of the tyrosine kinase receptor RET
(rearranged during transfection) [5]. Peripheral neurons innervating skin and mucosa show a
strong dependency on neurotrophic factors both ex vivo and in vivo [6,7]. In order to colonize
the PNS, HSV must reach FNE, dynamic structures capable of degeneration and regeneration
[8] in response to neurotrophic factors [6,7]. The possible relevance of neurotrophic factors in
the initial steps of HSV infection in neurons is not completely understood. We hypothesized
that HSV could modify nerve ending navigational cues during the early steps of
PNS colonization.
HSV glycoprotein G (gG) is the least conserved of the glycoproteins shared by HSV-1 and
HSV-2 [9]. HSV-1 gG (gG1) and HSV-2 gG (gG2) have a similar C-terminal domain present
at the virion and at the surface of the infected cells, composed by an extracellular proline-rich
domain, a transmembrane region and a short cytoplasmic tail. The N-terminal domain of
HSV-2 gG, but not that of gG1, is proteolytically cleaved and secreted (termed here SgG2) dur-
ing infection [10,11]. Whether these differences between gG1 and gG2 have any functional
consequence is unknown. Recombinant soluble gG1 (SgG1) and SgG2 bind chemokines with
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high affinity enhancing chemokine function [12], in sharp contrast to all previously described
viral chemokine-binding proteins (vCKBPs) that inhibit chemotaxis. Since neurotrophic fac-
tors are also secreted proteins regulating many aspects of peripheral neurons, and have been
previously involved in immune related-functions [13], we investigated whether HSV gG could
bind neurotrophic factors modifying their activity.
Here we show that SgG2 interacts with several neurotrophic factors. SgG2, but not SgG1 or
M3, a viral chemokine binding protein frommurine gamma herpesvirus 68 (MHV-68) [14], tran-
siently enhances NGF-dependent axonal growth of superior cervical ganglion (SCG) neurons ex
vivo. The molecular mechanism beneath this enhancement involves modulation of the NGF re-
ceptor TrkA. SgG2 alters TrkA localization in lipid rafts, and NGF-dependent TrkA internaliza-
tion, signaling and retrograde transport. In vivo, both infection with HSV-2 and expression of
SgG2 in the external layers of the epidermis modifies the termination zone of the TrkA dependent
FNE. Our data indicate that SgG2may reconfigure neurotrophin signaling during HSV-2 primary
infection to attract specific terminal axons to the infection site and may facilitate neural invasion.
Results
HSV gG interacts with neurotrophic factors
To test whether gG from HSV-1 or HSV-2 interacts with neurotrophic factors we performed
surface plasmon resonance (SPR) assays. As a control we used another vCKBP fromMHV-68,
M3. Recombinant SgG2 interacted with members of the neurotrophin family such as NGF and
those of the GFLs family, like artemin or GDNF (Fig.1A and S1 Table). SgG1 and M3 bound
neurotrophic factors but saturable binding was not demonstrated in these SPR experiments
and therefore non-specific binding cannot be excluded (S1A Fig. and S1 Table). However,
binding specificity was suggested by the lack of interaction of the vCKBPs tested with interfer-
on (IFN)-α, TNF-α, and interleukin (IL)-1, and the negative binding of M3 to artemin (Fig. 1B,
S1B Fig. and S1 Table). Saturation experiments using SPR further demonstrated the specific,
high affinity interaction of SgG2 and NGF (Fig. 1 D and S1 Table). We could also show binding
of SgG1 and SgG2 to NGF coupled in a chip (S1C Fig. and Fig. 1C, respectively), with a similar
affinity (KD 1.4 x 10
−8 M) to that calculated for NGF interacting with SgG2 coupled in a chip
based on kinetics analysis (not shown), supporting the specificity of the interaction. HSV-2 gly-
coprotein D (gD) was used as a negative control for NGF binding (Fig. 1C). We confirmed
binding of these vCKBPs to NGF by crosslinking assays using iodinated rat NGF ([125I]-rNGF)
and soluble, recombinant M3, SgG1 and SgG2 (S1D Fig. and S1 Text). The formation of the
vCKBP-NGF complex was competitively inhibited with increasing concentrations of unlabeled
NGF (S1E, F Fig.). Addition of increasing amounts of cold NGF resulted in the formation of
higher molecular weight bands that probably correspond to NGF oligomers since they appear
also in the absence of viral proteins. The formation of NGF oligomers at high concentration
may affect the pattern of binding to the viral proteins in our SPR assays.
Since HSV-1 and HSV-2 gG also bind chemokines, we tested whether NGF and chemokine
binding takes place through different regions or whether the binding sites overlap and the in-
teraction of NGF may be competitively inhibited with chemokines. We injected CXCL12β or
NGF alone or in combination with NGF in a chip containing SgG2. The binding detected after
simultaneous injection of chemokine and NGF nearly corresponded to the sum of the binding
obtained when the chemokine and NGF were injected independently (Fig. 1D). Furthermore,
injection of one of the analytes (NGF or CXCL12β) in an SgG2-coupled chip preincubated
with the other analyte (CXCL12β or NGF) caused no displacement of the prebound analyte
(not shown). It is important to note that the affinity of the interaction of SgG2 with CXCL12β
(2.2x10−9 M) [12] is higher than that determined for NGF (2.2x10−8 M).
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SgG2 enhances NGF-dependent axonal growth of SCG neurons
We addressed whether the vCKBP could affect the function of neurotrophic factors. FNE of
sensory neurons are the main targets of HSV-1 and HSV-2 in the skin and mucosa. We focused
on NGF and artemin due to their relevance in epidermal homeostasis and innervation [6,7]. In
order to have a feasible and robust model we used mouse sympathetic neurons from SCG that
express high levels of NGF and artemin receptors, and depend on NGF and artemin both in
vivo and in culture [15]. We cultured SCG as 3D explants using collagen matrix containing re-
combinant viral proteins, and we measured the area comprised by axons normalizing to the
ganglion perimeter. In the presence of NGF, SgG2 enhanced axonal growth of SCG neurons
compared to HEPES control (Fig. 2A, middle panels). On the contrary, M3 (Fig. 2A, middle
panels) did not induce such increase. No changes in axonal growth induced by SgG2 or M3
Figure 1. SgG2 interacts with NGF. (A) Sensorgram showing the interaction of SgG2 with increasing
concentrations of NGF. The concentrations of NGF are indicated at the right side of the sensorgram. (B)
Sensorgram showing the interaction of SgG2 with NGF and the lack of interaction with TNF-α, IFN-α and IL-1.
All analytes were injected at a 100 nM concentration. (C) Sensorgram depicting the interaction between
increasing concentrations of SgG2 and NGF coupled on a sensor chip. As a negative control we used the
same concentrations of purified HSV-2 gD. (D) Saturation curve for the binding of NGF to SgG2. The derived
KD is shown (E) Sensorgram showing the interaction of coupled SgG2 with CXCL12β and NGF injected
alone or in combination. In all cases the arrow indicates the end of injection. Abbreviations: Diff. Resp.,
Differential response; M, molar; R.U., response units; s, seconds.
doi:10.1371/journal.ppat.1004571.g001
HSV-2 SgGModifies NGF-TrkA Signaling
PLOS Pathogens | DOI:10.1371/journal.ppat.1004571 January 22, 2015 4 / 22
Figure 2. SgG2 increases NGF-dependent axonal growth. (A,B,D)Mouse SCGs were grown as explants in collagen matrix in the presence of the
indicated trophic factors and viral proteins. Neurons were stained with Tuj1 antibody targeting class III ß–tubulin. Nuclei were stained with TO-PRO-3.
Images are a projection of at least 3 stacks, correspond to the same experiment, and are representative of three (A,D) or two (B) independent experiments.
The graphs below represent the quantification from three (A,D) or two (B) independent experiments. To calculate significance, a two-tailed unpaired T-test
was applied. ***P<0.0001. (A) Explants were grown during 18 h. No trophic n = 7 each condition, NGF n = 13 each condition and artemin n = 9 each
condition. Scale bar, 100 μm. (B) Explants were grown during 24 h. n = 7 each condition. Scale bar 100 μm. Abbreviation: No t., No trophic factor. (C)Mouse
SCG dissociated neurons were grown during 18 h in the presence of NGF and viral proteins as indicated. Images are a projection of at least 5 stacks and
correspond to the same experiment. HEPES n = 172, SgG2 n = 103 and M3 n = 181. Scale bar 50 mm. The graph shows the quantification of the axonal area
for each condition. (D) Hanging drops containing transfected HEK-293T (on the left side of the images) were placed in the proximity of SCG explants and
grown during 48 h with NGF. n = 15 for each condition. Scale bar 100 μm. The bottom right panel shows the expression and secretion of viral proteins in
transfected HEK293T cell by western blot using an anti-V5 antibody.
doi:10.1371/journal.ppat.1004571.g002
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were detected in the absence of trophic factors (Fig. 2A, upper panels), or when artemin was
used (Fig. 2A, lower panels). Next, we addressed whether SgG1 had the same effect on NGF as
SgG2. SgG1 did not significantly increase axonal growth of SCG neurons 24 h post-incubation
(Fig. 2B). SgG2 enhancement of NGF-mediated axonal growth was also observed when using
dissociated SCG neurons (Fig. 2C). To further characterize this effect and to discriminate be-
tween axonal growth and directionality, transfected HEK-293T cells were co-cultured with
SCG in 3D explants with NGF, and the proximal/distal (P/D) ratio was analyzed. HEK-293T
cells express endogenous axonal repulsive cues like semaphorin 3A [16] and several class-A
ephrins [17]. Accordingly, using low concentrations of NGF (0.25 nM), control transfected
HEK-293T cells induced repulsion of SCG axons (Fig. 2D). Such repulsion was also observed
when HEK-293T cells were transfected with a V5-tagged M3-expressing plasmid (V5-M3). On
the contrary, the expression of V5-SgG2 significantly reduced the repulsion of SCG axons
(Fig. 2D middle panel). Viral protein expression was detected by Western blot (Fig. 2D). Alto-
gether, these data showed that SgG2 specifically increases axonal growth of SCG neurons in an
NGF-dependent manner.
SgG2 modifies NGF-TrkA signaling
We addressed whether the increase in NGF-dependent axonal growth mediated by SgG2 was
related to changes in TrkA. Since SgG2 bound NGF and modulated its function we decided to
address whether it could interact with TrkA. We incubated dissociated SCG neurons with NGF
in the presence or absence of SgG2. Following immunoprecipitation of TrkA, SgG2 was de-
tected only when NGF was present, indicating that SgG2 and TrkA belong to the same complex
in the presence of NGF and the interaction of SgG2 with NGF is required (Fig. 3A). Then we
focused on TrkA signaling. Dissociated cultures of SCG neurons were incubated with NGF,
M3 or SgG2 alone or NGF together with the viral proteins, and the downstream signaling was
analyzed by Western blotting. Incubation with SgG2 or M3 in the absence of NGF did not in-
duce TrkA phosphorylation or activation of downstream pathways (Fig. 3B–F). As expected,
NGF promoted TrkA phosphorylation [3]. SgG2 significantly increased NGF-dependent TrkA
phosphorylation at tyrosine 490 (Tyr490) at 15 min, but not at 120 min post-incubation, when
compared to control and M3 conditions (Fig. 3B,C). Extracellular signal-regulated kinases
(ERK)1/2 activation in response to NGF, but not that of AKT (also known as protein kinase B),
was significantly increased in the presence of SgG2 both at 15 and 120 min post-incubation
(Fig. 3B,D,E). We also tested the activation status of cofilin, an actin-severing protein responsi-
ble of actin turnover that is inactivated by phosphorylation [18]. We detected higher levels of
cofilin phosphorylation induced by SgG2-NGF 120 min post-NGF stimulation when com-
pared to NGF alone (Fig. 3B,F).
SgG2 alters localization of TrkA in lipid rafts
At the cell surface there are different and segregated types of rafts depending on their lipid and
glycosphingolipid composition, leading to diverse biological functions [19]. A fraction of TrkA
accumulates in GM1 lipid rafts, and TrkA appears to signal through GM1 rafts [20,21]. We ad-
dressed whether SgG2 could affect TrkA recruitment to GM1-enriched lipid rafts in SCG disso-
ciated neurons. In the absence of NGF, a small fraction of TrkA co-localized with GM1
staining (Fig. 4A, top row). As predicted, NGF stimulation maintained and increased TrkA co-
localization with GM1 staining 2 min post NGF stimulation (Fig. 4A, third row). SgG2 dis-
rupted NGF-dependent and-independent TrkA localization in GM1 rafts at 2 (Fig. 4A, fourth
row) and 10 min post-stimulation (Fig. 4B, fourth row). We hypothesized that SgG2 could di-
vert TrkA to other types of rafts such as GM3 rafts [19]. Stimulation with NGF reduced the
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localization of TrkA in GM3-rich rafts (Fig. 4C,D, third row) concomitantly with NGF-depen-
dent TrkA increase in GM1 rafts, when compared to HEPES treatment. However, addition of
SgG2 retained TrkA within GM3 rafts at 2 min post-incubation (Fig. 4C, fourth row) and even
Figure 3. SgG2modifies NGF-TrkA signaling.Mouse SCG dissociated neurons were grown during 5 days in vitro (DIV). (A) Neurons were deprived of
NGF for 16 h and were stimulated with NGF alone, NGF plus SgG2 or SgG2 alone during 5 min. TrkA-SgG2 interaction was analyzed by TrkA
immunoprecipitation (IP) followed byWestern blot (WB) to detect SgG2. Molecular sizes in kDa and the position of SgG2 (empty arrowhead) and TrkA (solid
arrowhead) are indicated. The experiment shown is representative of three independent assays. (B-F) Neurons were deprived of NGF for 16 h and were
stimulated with NGF and the indicated viral proteins during 0, 15 and 120 min. (B) The phosphorylation levels of TrkA, ERK, AKT and cofilin were analyzed
byWestern blot (WB) using specific antibodies. Detection of actin was used as a loading control. All blots correspond to the same experiment. Graphs show
statistical analysis for (C) p-TrkA, (D) p-ERK, (E) pAKT and (F) p-cofilin levels. p-TrkA n = 4; p-ERK n = 4; p-AKT n = 4; p-cofilin n = 3. To calculate
significance a two-tailed unpaired T-test was employed; *P<0.05; n.s: not significant.
doi:10.1371/journal.ppat.1004571.g003
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more at 10 min post-incubation (Fig. 4D, fourth row). Overall, our results indicated that SgG2
recruits TrkA to GM3-enriched lipid rafts, thereby altering the normal NGF-TrkA signaling
that usually occurs within GM1 rafts.
Figure 4. SgG2 promotes the incorporation of TrkA into different microdomains of the plasmamembrane.Mouse SCG dissociated neurons were
grown during 5 DIV. Neurons were deprived of NGF for 16 h and subsequently stimulated with NGF, vCKBPs or both. Colocalization between TrkA and two
different subtypes of lipid rafts was studied using immunofluorescence without permeabilization. TrkA colocalization with GM1 rafts 2 min (A) and 10 min (B)
post-stimulation. TrkA colocalization with GM3 rafts 2 min (C), and 10 min (D) post-stimulation. Confocal microscopy images correspond to one
representative cell from each condition. The +ves image displays pseudocolored pixels from the areas within the plasmamembrane in which both TrkA and
the corresponding subtype of lipid rafts pixel value exceed the mean. Scale bar represents 5 μm. Graphs show the average values (mean±SEM) obtained for
PC and ICQ. Plots in (A) represent n = 18–26 neurons from three independent assays. Plots in (B) show the results obtained for 15 cells from two
independent experiments. Plots in (C) represent n = 21–35 neurons from three independent assays. Plots in (D) represent 16–23 neurons from two
independent assays. Two-tailed unpaired T-test, *P<0.05; **P<0.001; ***P<0.0001.
doi:10.1371/journal.ppat.1004571.g004
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The NGF receptor p75NTR is present in GM1 rafts [20] and interacts with TrkA in an
NGF-dependent manner [3,22]. We addressed the effect of SgG2 on the interaction between
TrkA and p75NTR. As shown in S2 Fig., SgG2 disrupts the NGF-induced TrkA-p75NTR inter-
action in agreement with TrkA raft relocation mediated by SgG2, whereas SgG1 did not. As
TrkA recruitment to GM3 appeared to be independent of the presence of NGF in the culture
we wanted to determine whether SgG2 alone was sufficient to induce changes in TrkA signal-
ing. To explore this, we preincubated dissociated SCG neurons with HEPES or with SgG2 for
10 min followed by NGF stimulation in the presence or absence of SgG2. Preincubation with
SgG2 did not affect NGF dependent TrkA or ERK phosphorylation (S3A–C Fig.) and, in agree-
ment with Fig. 3B, changes on signaling were detected only when SgG2 was added together
with NGF. These results indicated that SgG2 induces TrkA raft relocalization that may be nec-
essary, but not sufficient, to enhance NGF-TrkA signaling.
SgG2 partially blocks NGF-dependent TrkA internalization and
retrograde transport
Careful examination of the results obtained following 10 min of NGF incubation (Fig. 4B,D)
suggested a possible effect of SgG2 at the level of plasma membrane TrkA. To confirm this ob-
servation we analyzed the internalization rate of TrkA in response to NGF and SgG2. Similar
amounts of TrkA were detected in almost every experimental condition in the absence of NGF
(Fig. 5A, time 0 min). Addition of 1 nM NGF promoted maximal TrkA internalization at 15
min post NGF incubation in both control (HEPES) and M3 conditions (Fig. 5A). However,
when SgG2 and NGF were added simultaneously we observed higher levels of TrkA at the plas-
ma membrane (Fig. 5A). Following 120 min of NGF exposure, this difference was maintained
although TrkA at the neuronal surface increased both in control and M3 conditions, probably
due to receptor recycling (Fig. 5A). In vivo, neurotrophins are secreted by specific tissues and
only the axon terminals are directly exposed to them [23]. For a suitable signaling on neurons
to occur, neurotrophins must be transported in a retrograde manner from distal axons to their
cell bodies. TrkA internalization seems to be required for TrkA retrograde transport [23]. Cofi-
lin is a critical mediator of TrkA retrograde transport [18]. Stimulation of SCG neurons with
NGF and SgG2 induced significant higher levels of cofilin phosphorylation, resulting in its in-
activation [24], at late time points (Fig. 3). We addressed the effect of SgG2 on TrkA retrograde
transport by monitoring the localization of phosphorylated TrkA (p-TrkA) on SCG neurons,
grown in microfluidic devices, whose axon terminals were incubated with NGF alone or in
combination with vCKBPs during 120 min. We found very low levels of p-TrkA in the distal
axons or cell bodies of neurons not exposed to NGF (Fig. 5B, upper row). As expected, expo-
sure of distal axons to NGF during 120 min promoted a moderate increase on p-TrkA staining
in distal axons and a high increase of p-TrkA staining in the cell bodies (Fig. 5B, second row).
Similar results were obtained when distal axons were exposed to NGF and M3 (Fig. 5B, fourth
row). Exposure of distal axons to NGF and SgG2 induced a significant accumulation of p-TrkA
staining in distal axons whereas low level staining was present in the cell bodies (Fig. 5B, third
row and graph). Moreover, the growth cone had a normal morphology following 120 min ex-
posure to NGF in both control and M3 conditions, with large actin-rich filopodial protrusions.
The presence of SgG2 severely disturbed growth cone morphology, presenting only few filopo-
dia (NGF-HEPES: 88,8% spread growth cones, NGF-M3 94,7% spread growth cones and
NGF-SgG2: 6,2% spread growth cones; P = 0,00303681, P = 0,00052529, respectively). Alto-
gether, these data indicated that SgG2 partially blocks NGF-dependent TrkA endocytosis and
retrograde transport with p-TrkA accumulating at the distal axon in the presence of NGF-
SgG2. Also, the actin cytoskeleton is perturbed.
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Figure 5. SgG2 reduces NGF induced TrkA internalization and retrograde transport. SCG dissociated
neurons were grown during 5 DIV and deprived of NGF for 16 h. (A) Neurons were stimulated with NGF alone
or together with the indicated viral proteins during 0, 15 and 120 min. TrkA internalization was analyzed by
immunofluorescence without permeabilization and normalized for F-actin using phalloidin staining. Solid
arrowhead points to a non-internalized cluster of TrkA at the plasmamembrane. Images show a projection of
at least 3 image planes. All images correspond to the same experiment, representative of two independent
experiments (n = 12 for each condition). Scale bar represents 5 μm. The graph shows the quantification of the
TrkA/phalloidin staining at the plasmamembrane over time in samples treated with NGF plus the indicated
HSV-2 SgGModifies NGF-TrkA Signaling
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SgG2 modifies peptidergic FNE termination zone in mouse epidermis
We hypothesized that SgG2-modification of NGF function could attract axons to infected sites
in vivo. NGF is secreted by keratinocytes in the skin [6]. In adult mice glabrous skin there are
two morphologically different intra-epidermal FNE, with distinct termination zones ([25],
Fig. 6A): (i) FNE that reach and meander through the stratum granulosum, an external layer of
epidermis (Fig. 6A, solid arrowhead), most of them being non-peptidergic and expressing
RET; and (ii) FNE with straight trajectory that remain in the inner stratum basale or stratum
spinosum (Fig. 6A, open arrowhead), most of them being from peptidergic TrkA+ neurons
[25–27].
Since SgG2 specifically modifies NGF-dependent TrkA+ signaling, we analyzed peptidergic
FNE in vivo during HSV-1 or HSV-2 infection. We topically applied PBS, HSV-1 or HSV-2
onto mice hindpaw (glabrous skin) following mild skin exfoliation. We did not detect any
macroscopical difference in the skin between the different conditions 48 h post-infection. We
detected HSV infection with an anti-gBgD antibody and the peptidergic FNE using an anti-cal-
citonin gene related peptide (CGRP) antibody. The number of peptidergic FNE was signifi-
cantly reduced in skin infected with both HSV-1 and HSV-2 (Fig. 6B). Most peptidergic FNE
remained in the stratum basale or in the stratum spinosum in PBS-treated skin, as described
[25] (Fig. 6C left panel, 6D left panel). HSV-1 infection promoted a subtle, although not signifi-
cant, change in the trend of the termination zone of the remaining peptidergic FNE (Fig. 6C,
right panel). However, following HSV-2 infection nearly half of the remaining peptidergic FNE
increased in length, reaching the stratum granulosum (Fig. 6D, right panel).
We hypothesized that changes in straight peptidergic FNE termination zone induced by
HSV-2, but not by HSV-1, could be mediated by SgG2 through its interaction with NGF. We
transfected mice hindpaw skin with empty vector or viral cDNA coding for V5-SgG2 or V5-
M3. Transfection did not affect epidermal layers, general nerve arrangement or the number of
peptidergic FNE per field in all the conditions tested. In vector-transfected skin, nearly all
straight trajectory-peptidergic FNE remained in the stratum basale or in the stratum spinosum,
(Fig. 6E, left panel, 6F left panel). However, in the fields where V5-SgG2 expression was de-
tected, around 20% of straight trajectory-peptidergic FNE showed increased length, reaching
the stratum granulosum (Fig. 6E, right panel). This phenomenon was not detected when V5-
M3 was expressed (Fig. 6F, right panel). Altogether these data suggested that HSV-2, but not
HSV-1, modifies the termination zone of the straight peptidergic FNE and that SgG2 may ac-
count, at least partially, for this phenomenon.
Discussion
Neurotropism is a major evolutionary advantage for HSV. The infection of neuronal FNE per-
mits HSV to establish latency in sensory ganglia and persist for the lifetime of the individual.
We have detected that infection of glabrous skin with HSV-1 and HSV-2 causes a reduction in
the number of peptidergic FNE. This could be due to the secretion of neurotoxic molecules fol-
lowing infection, such as IL-1β and TNF-α [28,29]. HSV may have developed molecular mech-
anisms to counteract this toxicity. The presence, plasticity and topology of FNE during
protein or buffer. (B)Mouse SCG dissociated neurons were grown during 7 DIV using microfluidic devices.
Neurons were deprived of NGF for 16 h and NGF and viral proteins were added to the distal axon
compartment during 120 min. TrkA phosphorylation was analyzed by immunofluorescence after
permeabilization with Triton X-100 and normalized using phalloidin. The images and the graph correspond to
the same experiment and are representative of three independent experiments. Scale bar 10 μm. n = 10
fields for each condition. A two-tailed unpaired T-test was used to calculate significance in (A) and (B).
***P<0.0001.
doi:10.1371/journal.ppat.1004571.g005
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Figure 6. V5-SgG2 transfection in the epidermis modifies the termination site of peptidergic FNE. (A)
Image of FNE in the mouse epidermis stained with anti-PGP 9.5, a pan-neuronal marker. The image shows
the different morphologies of the FNE. Solid arrowhead points to a FNE with morphology that fits with the
majority of the non-peptidergic FNE. Open arrowhead points to a FNE with morphology that fits with the
majority of the peptidergic FNE. (B)Graph representing the number of peptidergic FNE per field in infected
and non-infected mouse hindpaw epidermis. (C, D)Mouse hindpaw epidermis was treated with PBS (right
hindpaw) or infected with HSV-1 (C) or HSV-2 (D) (left hindpaw) and stained with and anti-gBgD antibody to
detect HSV and the anti-CGRP antibody to detect the peptidergic FNE. Termination zone of FNE was
determined and quantified. Images show the projection of at least 3 planes. 4 mice were infected and 15
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development and adult remodeling depend on axonal navigational cues and trophic factors like
neurotrophins. Our results show that HSV-2 SgG specifically binds to several neurotrophic fac-
tors from the neurotrophin family (NGF, BDNF and NT3) and the GFL family (GDNF and arte-
min). Interactions of HSV-1 gG andMHV-68M3 with neurotrophic factors were also observed
but we cannot rule out the possibility that these interactions are non-specific. Further research
may identify biological relevance for these interactions in the biology of HSV-1 and MHV-68.
Only the interaction between SgG2 and NGF is biologically relevant in our experimental model
resulting in an increase in FNE growth of TrkA+ neurons. This constitutes the first description,
to our knowledge, of a protein expressed by a human pathogen with the ability to modulate neu-
rotrophic factors and we hypothesize that this interaction may contribute to HSV neurotropism.
To test this hypothesis we focused our functional studies on neurotrophic factors regulating
innervation of the epidermis and that are important in skin homeostasis and inflammation,
like NGF and artemin [6,7,13]. Using SCG explants and dissociated cultures, only SgG2, but not
SgG1 or M3, modified NGF-dependent axonal growth ex vivo. In vivo only SgG2 modified the
growth and termination site of the TrkA+ FNE, corresponding to peptidergic neurons. Impor-
tantly, similar results were observed when infecting the skin with HSV-2 but not with HSV-1.
One of the most intriguing results of our work is the difference between HSV-1 and HSV-2.
HSV-1 seroprevalence is higher than that of HSV-2 [30–32]. HSV-1 is normally transmitted
during childhood and is linked to facial herpes whereas HSV-2 is normally sexually transmitted
and associated with genital herpes. However, both viruses can infect these two anatomical
areas, and genital herpes due to HSV-1 is increasing [31,33]. Of note, HSV-1 reactivates in the
genital tract less frequently than HSV-2 [34]. Therefore, differences in prevalence, transmission
route and recurrent disease between HSV-1 and HSV-2 in the oro-labial or genital area exist.
The lack of effect with HSV-1 in our in vivo experiments does not rule out the possibility that
HSV-1 may modulate neurotrophic factors in another setting or utilizes a different mechanism
to modulate axonal growth. In this regard, HSV-1 latency associated transcript induces axonal
regeneration and growth in a post-entry phase following serum deprivation [35] or NGF star-
vation [36], and this could facilitate release of HSV-1 into the peripheral tissue following anter-
ograde transport from the neuronal cell body [36]. From a molecular perspective, the different
activity of gG1 and gG2 could be due to their structure and location. HSV-1 gG is a transmem-
brane protein that remains anchored at the surface of infected cells and the virion envelope
whereas gG2 is proteolytically processed secreting an N-terminal domain, SgG2, with the po-
tential of reaching neighboring cells.
Mature peptidergic neurons express TrkA. These type of FNE represent 40% of the total
FNE in glabrous skin [25], but they are the predominant population in mucosa and in the in-
ternal organs [37,38]. The fact that HSV-2 displays a specific molecular mechanism involved in
attracting peptidergic FNE points to possible implications on a more efficient colonization of
different anatomical niches or subsets of neurons. In this regard, recent evidence indicates that
sensory A5+ neurons (corresponding to CGRP+/TrkA+ neurons) support HSV-2 productive
infection while they are non-permissive for HSV-1 productive infection in vitro [39]. This dif-
ference in susceptibility is dependent on the latency associated transcript [40]. Whether the lack
fields were analyzed for each condition. (E, F)Mouse hindpaw epidermis was transfected with empty vector
(right hindpaw) or with a V5-SgG2 (E) or V5-M3 (F) construct (left hindpaw) and stained with the peptidergic
marker antibody anti-CGRP and anti-V5 epitope. Termination zone of FNE was determined and quantified.
Images show the projection of at least 3 planes. The experiment shown is representative of 3. 15 fields were
analyzed for each condition. In (A-F) the discontinuous white lines are shown to indicate the separation
between the different layers of the epidermis. Scale bar 10 μm. A two-tailed unpaired T-test was used to
calculate significance. **P<0.001; ***P<0.0001.
doi:10.1371/journal.ppat.1004571.g006
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of HSV-1 effect on TrkA+ FNE shown here may influence A5+ neuron susceptibility requires fur-
ther investigation. The genitalia are enriched in TrkA-expressing peptidergic innervation [41,42].
For instance, TrkA+ projecting neurons rise up to 60% from first sacral ganglia to rat penis [43].
We propose that SgG2 may facilitate the infection of FNE innervating the genitalia and/or subse-
quent spread. In agreement with this hypothesis, pharmacological modulation of capsaicin-sensi-
tive peptidergic neurons reduces the severity of cutaneous HSV-2 genital infections both in
female and male pigs [44]. Alternatively, infection of peptidergic neurons may be relevant for
nociception. In summary, we cannot conclude from our study that HSV-2 SgG-mediated modu-
lation of NGF is essential for the infection of FNE and subsequent colonization of the nervous sys-
tem, but our data lead us to propose that SgG2 may facilitate the infection of specific subsets of
neurons and this may have consequences for transmission and disease. Deletion or disruption of
us4, the gene encoding gG, in HSV-1 results in partial attenuation in mouse models of infection
[45–47]. There are no reports analyzing the role of gG2 in vivo using animal models.
Transient enhancement of NGF-mediated axonal growth by SgG2 involves several related
events affecting TrkA localization and trafficking. SgG2 alone modifies TrkA association with
gangliosides, increasing its relative presence in GM3- versus GM1-rich rafts. This effect could
be mediated by the SgG2 ability of binding glycosaminoglycans (N. M.-M., A. V.-B. and
A. A. submitted manuscript)). However SgG2 mediated TrkA recruitment to GM3 is not suffi-
cient to induce changes in TrkA signaling by itself. SgG2 must be bound to NGF to promote
the described changes as previously observed for SgG2 enhancement of chemokine function
[12]. GM1 is the preferential ganglioside for canonical NGF-TrkA signaling [21]. GM1 is a
marker of caveolae and caveolae-like membranes [20]. The SgG2-mediated TrkA exclusion
from GM1 rafts may influence the function of TrkA and could explain the reduced TrkA-
p75NTR interaction upon NGF stimulation since p75NTR is located mainly within caveolae
and caveolae like membranes [20]. TrkA-p75NTR interaction appears to be required for NGF-
TrkA endocytosis in some models [22] and could account at least partially for the reduced
TrkA endocytosis detected in the presence of SgG2 during NGF stimulation. The fact that
TrkA is a raft resident protein [48], whereas RET remains outside lipid rafts and is transiently
recruited to rafts upon binding to GFLs in cis [49,50], could explain the lack of SgG2 effect on
Artemin function. Since TrkA endocytosis is a pre-requisite for its retrograde transport
[18,51], this could explain the blockage of NGF-mediated TrkA retrograde transport caused by
SgG2. Finally, accumulation of p-TrkA in distal axons mediated by NGF-SgG2 could induce a
local increase in axon length as proposed for NT-3 activation of TrkA [51,52]. The SgG2-NGF-
TrkA complex promotes an aberrant downstream signaling. The enhanced NGF-mediated
TrkA phosphorylation in the presence of SgG2 could be due to the presence of higher levels of
TrkA at the plasma membrane, to differences in NGF-TrkA sensitivity, or to the modification
of TrkA-ganglioside association since the raft environment determines the interaction of recep-
tors with specific signaling components [19]. One of the most intriguing questions that arise
from SgG2-NGF-TrkA signaling resides in the long-term inactivation of cofilin through phos-
phorylation. Cofilin is an actin-severing protein that regulates actin turnover [24]. Besides,
cofilin is a key component of the TrkA retrograde transport complex [18]. Our data showed
that SgG2 blocks NGF-induced TrkA retrograde transport and disturbs growth cone morphol-
ogy. Both results are in agreement with the observed phosphorylation of cofilin. An increased
amount of p-TrkA in distal axons may lead to a rapid and transient axonal growth. Growth
cones appear to function as a probe [53], and exposure to SgG2-NGF reduces filopodia result-
ing in a blunt growth cone. These blunt growth cones could be less responsive to repulsive nav-
igational guidance cues and, together with an increased TrkA and ERK signaling, may reach
distant, non-permissive sites. All these molecular events promoted by SgG2, raft relocation of
TrkA, reduced internalization of TrkA in response to NGF and activation of modified NGF
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signaling pathway, appear to be interconnected finally resulting in the invasion of external epi-
dermal layers by peptidergic FNE when SgG2 is ectopically expressed in mouse footpad skin,
probably facilitating HSV-2 access to this type of FNE.
We have shown that HSV gG is a vCKBP with the unique property of enhancing the activity
of chemokines [12], immune proteins involved in the migration and activation of leukocytes
[54]. Both gG1 and gG2 potentiate chemokine-mediated migration in vitro and in vivo, and
this may facilitate the infection of cells recruited to areas of infection and thereby virus dissemi-
nation to other tissues. The migration of uninfected epithelial cells towards HSV infected sites
has been shown [55] supporting the ability of HSV to modulate cell migration. Here we dem-
onstrate that HSV SgG2 interacts with neurotrophic factors and enhances NGF-dependent
growth of FNE to sites of infection probably facilitating transmission to the PNS. Interestingly,
SgG2 uses a common mechanism to enhance chemokine and NGF activity, causing the reloca-
lization of their receptors to specific ganglioside-rich sites in the plasma membrane and delay-
ing the internalization rate of the receptors, increasing their levels at the cell surface (this
report and N. M.-M., A. V.-B. and A.A., manuscript submitted). SgG2 seems to bind both che-
mokines and NGF simultaneously and this property could play a relevant role during in vivo
infection due to the contribution of chemokines and neurotrophins in the crosstalk between
the immune and nervous system. Chemokines are essential in the antiviral response but they
can also modulate the responsiveness of axons to guidance cues, acting as antagonists of axonal
repulsion and inducing axonal sprouting [56–58]. Neurotrophic factors are essential elements
of the nervous system and also play relevant roles in inflammation and pain modulation [59].
NGF is the major contributor of axonal growth of peptidergic neurons and a key component of
the neurogenic inflammatory response in the epidermis in response to stress or under patho-
logical conditions, permitting a coordinated response between immune cells and peptidergic
neurons [60–62]. Our results in vitro, ex vivo and in vivo, lead us to propose that SgG2 modifies
NGF-TrkA signaling to induce peptidergic neurons to grow to external layers of the epidermis,
facilitating access of HSV-2 to peptidergic neurons.
This is, to our knowledge, the first example of a viral protein, encoded by a highly prevalent
neurotropic human pathogen that interacts with components of both immune and nervous
systems, and both activities may help HSV-2 to reach FNE to establish latency in neurons. A
similar strategy may be used by other relevant human pathogens. The interaction of SgG2 with
neurotrophic factors sheds light on the complex network of virus-host interactions and uncov-
ers a new molecular framework to investigate the colonization of the nervous system by HSV-
2, an important human pathogen.
Materials and Methods
Ethics statement
All animal experiments were performed in compliance with national and international regula-
tions and were approved by the Ethical Review Board of the Centro de Biología Molecular
Severo Ochoa under the project number SAF2009–07857. The procedures employed complied
with the National (“Real Decreto” 1201/2005 and 53/2013) and European (Directives 86/609/
CEE and 53/2013) regulations.
Determination of vCKBP-neurotrophic factor binding specificity and
affinities
The interactions between neurotrophic factors and vCKBPs were characterized by SPR tech-
nology as before [63], with Biacore X and X100 biosensors (GE Healthcare). SgG1, SgG2 and
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M3 were coupled to CM4 or CM5 Biacore chips through amine coupling. In the screening ex-
periment, to determine binding to SgG1, SgG2 and M3, neurotrophic factors (Peprotech) were
injected at 100 nM in HBS-EP buffer (10 mMHEPES, 150 mM, NaCl, 3 mM EDTA, 0.005%
(vol/vol) surfactant P20, pH 7.4) at a flow rate of 10 μl/min, and association and dissociation
were monitored. Other analytes used (IFN-α, TNF- α and IL-1, Peprotech) were also injected
at 100 nM. To determine the association and dissociation kinetics, different concentrations of
neurotrophic factors (with the exception of artemin) were injected at a flow rate of 30 μl/min,
and association and dissociation were monitored. The number of relative units in each chip
was 831 (for SgG1), 187 (for SgG2) and 375 (for M3). Artemin was coupled to a CM5 chip and
different concentrations of SgG1, SgG2 and M3 were injected. Human NGF was coupled to a
CM4 chip and different concentrations of SgG1, SgG2 and HSV-2 gD were injected. In some
experiments NGF and CXCL12β were injected alone or in combination into a chip containing
SgG2 to address whether SgG2 could bind both simultaneously. All Biacore sensorgrams were
analyzed with the software Biaevaluation 3.2 and Evaluation 2.0.1 (for sensorgrams obtained
with the Biacore X and Biacore X100, respectively)
Culture of explants of SCG in collagen matrix
Mouse sympathetic SCG were cultured in a 3D collagen matrix [64]. In brief, 340 μL of rat tail
collagen I (BD Biosciences, San Jose, CA) were mixed with 40 μL of 10x MEM, 10 μL of HEPES
or the vCKBPs at a final concentration of 50 nM, and mouse NGF 2.5S (N-100, Alomone labs,
Jerusalem, Israel) at a final concentration of 0.25 nM. This mix was neutralized using 0.8 M
NaHCO3, and immediately spotted in drops where ganglia were included.
Culture of dissociated SCG neurons
Mouse sympathetic neurons from SCGs were cultured as previously described [65]. Ganglia
were dissected from newborn mice (postnatal day 0–1), digested in collagenase and trypsin
(Worthington, Lakewood, NJ), dissociated by trituration and plated on dishes previously coat-
ed with rat tail collagen I (BD Biosciences) in DMEM containing 50 ng/mL NGF (Alomone
labs), 10% fetal bovine serum and 5ng/mL of aphidicolin (A.G. Scientific, San Diego, CA) for
5–7 days. For retrograde transport analysis SCG neurons were cultured in polylysine (100 μg/
mL)—laminin (10 μg/mL) using microfluidic devices AXIS Axon Isolation Devices, 450um
fromMillipore (Billerica, MA)
Cell culture and HEK-293T transfections
HEK-293T were cultured in MEM, 10% FBS and antibiotics. HEK-293T were transfected with
Lipofectamine 2000 (Life Technologies, CA, USA) according to the manufacturer´s instruc-
tions, and 6 h after transfection the cells were detached to prepare cell aggregates using the
“hanging drop”method [64].
Treatments of SCG neurons
Dissociated neurons were grown during 5 to 7 days in vitro (DIV) and starved of NGF during
16 h when indicated. NGF and vCKBP were mixed in DMEM prior stimulation. To calculate
NGF molarity we considered NGF as a dimer (26kDa). The concentrations used were 0.5 nM
NGF with 100 nM vCKBP for signaling experiments; 1 nM NGF with 200 nM vCKBP for
TrkA-p75 interaction analysis and TrkA internalization assays; and 5 nM NGF with 1 μM
vCKBPs were applied in the distal axon compartment for retrograde transport analysis.
HSV-2 SgGModifies NGF-TrkA Signaling
PLOS Pathogens | DOI:10.1371/journal.ppat.1004571 January 22, 2015 16 / 22
Quantitative colocalization
Pearson´s coefficient (PC) is a standard statistical analysis designed to measure the strength of
a linear relationship between two variables, in this case fluorescent intensities from two images.
PC generates a range of values from 1, a perfect positive correlation, to −1, a perfect but inverse
correlation, with 0 representing a random distribution. The intensity correlation analysis
(ICA) [66] method is based on the principle that if two proteins are part of the same complex
then their staining intensities should vary in synchrony, whereas if they form part of different
complexes or structures they will exhibit asynchronous staining. Intensity correlation quotient
(ICQ) was used to provide an overall index of whether the staining intensities were associated
in a random, a dependent or a segregated manner. Given that the outlining of regions in which
two probes may distribute is required to obtain accurate measurements of colocalization, we
drew regions of interest (ROI) corresponding to the entire plasma membrane of the neuron,
where the colocalization analysis was carried out. A minimun of three different sections were
quantified in the assays shown. ICA analysis was perfomed using Image J 1.43 software.
In vivo infection and transfection of glabrous skin
Mice were anesthetized with a mixture of ketamine xylazine prior to infection. A region located
between proximal pads and heel of ventral hindpaw was exfoliated by rubbing the skin 30 times
with an exfoliation sponge (3 M, Heavy Duty), followed by tape stripping. This procedure results
generally in transient and mild erythema but not in hemorrhage and scar formation [67]. Follow-
ing exfoliation 10 μL of PBS, HSV-1 or HSV-2 containing 1x104 plaque forming units were ap-
plied on the footpad. To transfect mouse hindpaw skin, a similar exfoliation procedure was used.
The DNA was transfected using In-vivo Jet Pei (Polyplus Transfection, Illkirch, France) [67].
FNE staining
Mice were euthanatized 48 h after in vivo transfection or infection. Transfected or infected
hindpaw skin was immediately removed by using a 3 mm biopsy punch and fixed in Zamboni
´s fixative for 6 h. Then biopsies were washed, cryoprotected in 20% sucrose for 24 h, embed-
ded in OCT and sectioned. Staining of FNE was performed by adapting previously established
protocols [25,68]. 40 μm free floating sections were washed in PBS with 0.3% Triton X-100
(PBS+TX), blocked for 30 min in 10% horse serum in PBS+TX. Antibodies used for FNE stain-
ing were anti-protein gene product (PGP) 9.5 rabbit antibody (Cedarlane-Ultraclone, Ontario,
Canada) and anti-CGRP rabbit antibody. Anti V5-tag mouse antibody to detect viral proteins
containing a V5 tag was from Sigma. Secondary antibodies used for immunostaining were
from Sigma. Confocal analysis was performed with LSM 510 Confocal Laser Scanning Micro-
scope from Carl Zeiss. Analysis and treatment of images was performed using LSM Image
Browser, Fiji and Adobe Photoshop.
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S1 Fig. Interaction between vCKBPs and NGF. (A) Sensorgrams showing the interaction of
Sg1 and M3 with increasing concentrations of NGF. The concentrations of NGF are indicated
at the right side of each the sensorgram. (B) Sensorgrams showing the interaction of SgG1 and
M3 with NGF and the lack of interaction with TNF-α, IFN-α or IL-1. All analytes were injected
at a 100 nM concentration. (C) Sensorgrams depicting the interaction between increasing con-
centrations of SgG1 with NGF coupled on a sensor chip. Abbreviations: Diff. Resp., Differential
response; R.U., response units; s, seconds. (D-F) Crosslinking assays showing the interaction of
1 nM [125I]-rNGF with SgG1, SgG2 and M3. (E, F) Crosslinking assay between 1 nM [125I]-
rNGF and SgG2 (E) or M3 (F) in the presence of increasing concentrations of unlabeled NGF
(0, 80, 160 and 320 nM in E and 0, 160, 320 and 640 nM in F). Molecular masses are indicated
in kDa. SgG-NGF complexes are indicated with arrows and non-specific signals are marked
with asterisks.
(TIF)
S2 Fig. SgG2 disrupts NGF-dependent TrkA-p75NTR interaction. (A)Mouse SCG dissoci-
ated neurons were grown during 5 DIV. Neurons were deprived of NGF for 16 h and stimulat-
ed with NGF, vCKBPs or both during 2 min at 37°C. Following stimulation, cells were PFA-
fixed and TrkA-p75NTR interaction at the plasma membrane was analyzed by immunofluo-
rescence without permeabilization. Confocal microscopy images correspond to one representa-
tive cell from each condition. A region of the plasma membrane of each neuron is shown in the
zoom image. The +ves image displays pseudocolored pixels from the areas within the plasma
membrane in which both TrkA and p75NTR pixel value exceed the mean. Scale bar represents
10 μm. (B) Pearson´s coefficient (PC) and intensity correlation quotient (ICQ) were calculated
for TrkA and p75NTR colocalization. Bar plots show mean±SEM for n = 20 cells from two in-
dependent assays. Two-tailed unpaired T-test, P<0.05; P<0.001. (C)Mouse SCG dissociat-
ed neurons were grown during 5 DIV. Neurons were deprived of NGF for 16 h and were
stimulated with NGF alone or NGF plus SgG2 during 5 min. TrkA-p75NTR interaction was
analyzed by TrkA immunoprecipitation followed by western blot to detect p75NTR. The ex-
periment shown is representative of three independent assays.
(TIFF)
S3 Fig. Preincubation of neurons with SgG2 it is not sufficient to induce increased TrkA
signaling.Mouse SCG dissociated neurons were grown during 5 days in vitro (DIV). Neurons
were deprived of NGF for 16 h, preincubated with HEPES or 100nM SgG2 for 10 min and then
stimulated with 0.5nM NGF and HEPES or 0.5nM NGF and 100nM SgG2 for 15 min. (A) The
phosphorylation levels of TrkA and ERK were analyzed byWestern blot using specific antibod-
ies. (B) Graph showing statistical analysis for TrkA phosphorylation (n = 6). (C) Graph show-
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